Quick Answer
Silexion Therapeutics Corp reported Total Assets of $7.22 million for the year ending 2025.
- Silexion Therapeutics Corp showed an increase of +152.0% in Total Assets from 2024 to 2025.
- This data is from Silexion Therapeutics Corp's annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2024: $3.59 million | Q2 2024: $2.32 million | Q3 2024: $3.09 million | Q1 2025: $8.31 million | Q2 2025: $5.80 million | Q3 2025: $11.61 million.
- Over the full 3 years of available data (2023 to 2025), Silexion Therapeutics Corp's Total Assets has grown by 37.3%.
- Historical annual values: Fiscal year 2025: $7.22 million | Fiscal year 2024: $2.86 million | Fiscal year 2023: $5.26 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: